A follow-up study showed that CADD522 also inhibited mitochondrial oxidative phosphorylation by decreasing the oxygen consumption rate plus ATP production in human breast cancer cells in a RUNX2-independent manner [46]. This evidence concerns the gene RUNX2 and breast cancer.